Multiple drugs are known to induce metabolic malfunctions, among them second-generation antipsychotics (SGAs). The pathogenesis of such adverse effects is
atypical antipsychoticsbest practice alertcomputerized decision support systemclinical pharmacymetabolic monitoringmetabolic syndromesecond-generation antipsychoticsWhat is known and objective Metabolic syndrome is a well-documented adverse effect of second-generation antipsychotics (SGAs). Patients with metabolic ...
The patient reported that her prior medication trials included SSRIs (1), SNRIs (1), atypical antidepressants (2), tricyclic antidepressants (TCAs) (2), first-generation antipsychotics (1), SGAs (2), benzodiazepines (2), Z-drugs (1), and stimulants (1). At the time of the assessment...
Statistical Analysis: Chi square chart and Unpaired t-test were used for statistical analysis using a computer. Results: 11.66% of the patients developed metabolic syndrome after 4 months of antipsychotic medication. Conclusions: Second-generation antipsychotics cause significantly more changes in the ...
Objective: To determine whether implementation of a metabolic monitoring training program (MMTP) in an urban community-based setting improved monitoring in children treated with second-generation antipsychotics (SGAs) and changed prescription rates of SGAs to children. Method: The MMTP was implemented in...
Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics.doi:10.1111/inm.12407Elena SeveriMaria FerraraEnrico TedeschiniFrancesca VaccaFrancesco MungaiRocco Amendolara...